Test-Cyp250 Testosterone Cypionate Injection USP 250 mg COMPOSITION: Each 1ml contains: Testosterone Cypionate USP 250mg PHARMACOLOGICAL CLASSIFICATIONS: Male sex hormones PHARMACOLOGICAL ACTION: In the eunuch and eunuchoid male, androgens act to stimulate and maintain the secondary sexual characteristics associated with the adult male. Androgens influence closure of the epiphyseal lines in males and some females, administration of androgens reduces urinary excretion of nitrogen, sodium, potassium, chloride, phosphorus and water. INDICATIONS: Based on a review by the National Academy of Sciences - National Research Council and/or other information, FDA has classified the indications for certain androgens as follows: Effective - In the male: 1.Eunuchism, eunuchoidism, deficiency after castration. 2.Male climacteric symptoms when these are secondary to androgen deficiency, 3.Oligospermia. Probably Effective - in the female or male: 1. Postmenopausal or senile osteoporosis. Androgens are without value as a primary therapy, but may be of value as adjunctive therapy. Equal or greater consideration should be given to diet, calcium balance, physiotherapy, and good general health-promoting measures. Final classification of the less-than-effective indications requires further investigation. CONTRA-INDICATIONS: Carcinoma of the male breast. Carcinoma known or suspected of the prostate. Cardiac, hepatic or renal decompensation. Hypercalcaemia. Liver function impairment. Prepubertal males. Pregnancy. SIDE EFFECTS AND SPECIAL PRECAUTIONS: Hypercatcaemia may occur in immobilized patients, and in patients with breast cancer. In patients with cancer this may indicate progression of bony metastasis. If this occurs the drug should be discontinued. Testosterone propionate must not be used interchangeably with testosterone cypionate, enanthate or phenylacetate due to the difference in duration of action.